Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

被引：0
|
作者：
J. Rosenstock
V. Fonseca
J. B. McGill
M. Riddle
J.-P. Hallé
I. Hramiak
P. Johnston
M. Davis
机构：
[1] Dallas Diabetes and Endocrine Center at Medical City,
[2] University of Texas Southwestern Medical School,undefined
[3] Tulane University Medical Center,undefined
[4] Washington University School of Medicine,undefined
[5] Oregon Health and Science University,undefined
[6] Université de Montréal,undefined
[7] University of Western Ontario,undefined
[8] sanofi-aventis,undefined
[9] University of Wisconsin School of Medicine and Public Health,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
CSME; ETDRS; Insulin action; Insulin glargine; Insulin therapy; NPH insulin; Retinopathy; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1778 / 1788
页数：10
相关论文
共 50 条
  • [1] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
    Rosenstock, J.
    Fonseca, V.
    McGill, J. B.
    Riddle, M.
    Halle, J. -P.
    Hramiak, I.
    Johnston, P.
    Davis, M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1778 - 1788
  • [2] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]
    Rosenstock, J.
    Fonseca, V.
    McGill, J. B.
    Riddle, M.
    Halle, J. -P.
    Hramiak, I.
    Johnston, P.
    Davis, M.
    [J]. DIABETOLOGIA, 2009, 52 (10) : 2236 - 2239
  • [3] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]
    J. Rosenstock
    V. Fonseca
    J. B. McGill
    M. Riddle
    J.-P. Hallé
    I. Hramiak
    P. Johnston
    M. Davis
    [J]. Diabetologia, 2009, 52 : 2236 - 2239
  • [4] Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
    Rosenstock, J.
    Fonseca, V.
    McGill, J. B.
    Riddle, M.
    Halle, J. P.
    Hramiak, I.
    Johnston, P.
    Davis, M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1971 - 1973
  • [5] Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
    J. Rosenstock
    V. Fonseca
    J. B. McGill
    M. Riddle
    J. P. Hallé
    I. Hramiak
    P. Johnston
    M. Davis
    [J]. Diabetologia, 2009, 52 : 1971 - 1973
  • [6] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
  • [7] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [8] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
    Min Liu
    Zhiguang Zhou
    Jinhua Yan
    Pin Li
    Wenhui Song
    Junfen Fu
    Xiaobo Chen
    Weigang Zhao
    Li Xi
    Xiaoping Luo
    Liang Sha
    Xueyuan Deng
    Chunxiu Gong
    [J]. BMC Endocrine Disorders, 16
  • [9] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
    Liu, Min
    Zhou, Zhiguang
    Yan, Jinhua
    Li, Pin
    Song, Wenhui
    Fu, Junfen
    Chen, Xiaobo
    Zhao, Weigang
    Xi, Li
    Luo, Xiaoping
    Sha, Liang
    Deng, Xueyuan
    Gong, Chunxiu
    [J]. BMC ENDOCRINE DISORDERS, 2016, 16 : 67
  • [10] Similar progression of diabetic retinopathy with glargine or NPH insulin in type 2 diabetes (T2D)
    Rosenstock, Julio
    Fonseca, Vivian
    McGill, Janet
    Riddle, Matthew
    Halle, Jean-Pierre
    Hramiak, Irene
    Johnston, Peter
    Davis, Matthew
    [J]. DIABETES, 2008, 57 : A86 - A86
12345